MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Phibro Animal Health Corporation Cost of Revenue 2011-2025 | PAHC
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Phibro Animal Health Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 896 M | 705 M | 680 M | 657 M | 562 M | 543 M | 563 M | 553 M | 516 M | 512 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 896 M | 512 M | 619 M |
Quarterly Cost of Revenue Phibro Animal Health Corporation
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 244 M | 243 M | 207 M | 177 M | 184 M | 171 M | 164 M | 170 M | 167 M | 164 M | 331 M | 168 M | 162 M | 150 M | 312 M | 143 M | 138 M | 131 M | 138 M | 131 M | 145 M | 132 M | 145 M | 132 M | 150 M | 134 M | 150 M | 134 M | 139 M | 130 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 331 M | 130 M | 170 M |
Cost of Revenue of other stocks in the Care facilities industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Amedisys
AMED
|
1.33 B | - | 0.01 % | $ 3.3 B |  USA |
 |
Apollo Medical Holdings
AMEH
|
1.17 B | - | -2.11 % | $ 1.84 B | USA |
 |
American Shared Hospital Services
AMS
|
19.2 M | $ 2.11 | 1.44 % | $ 13.7 M | USA |
 |
Avalon GloboCare Corp.
AVCO
|
1.43 M | - | 26.45 % | $ 70.6 M | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
463 M | $ 3.6 | -16.56 % | $ 472 M |  China |
 |
Community Health Systems
CYH
|
1.95 B | $ 3.24 | 0.47 % | $ 428 M | USA |
 |
Chemed Corporation
CHE
|
1.58 B | $ 433.04 | -0.43 % | $ 6.51 B | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
12.5 B | $ 24.07 | 0.08 % | $ 7.05 B |  Germany |
 |
Elanco Animal Health Incorporated
ELAN
|
2 B | $ 22.6 | 1.03 % | $ 11.2 B | USA |
 |
Acadia Healthcare Company
ACHC
|
1.69 B | $ 14.63 | 2.31 % | $ 1.34 B | USA |
 |
AMN Healthcare Services
AMN
|
2.54 B | $ 16.14 | 0.81 % | $ 632 M | USA |
 |
Aesthetic Medical International Holdings Group Limited
AIH
|
376 M | - | 10.96 % | $ 46.2 M | China |
 |
HCA Healthcare
HCA
|
29.5 B | $ 476.83 | 0.61 % | $ 130 B | USA |
 |
IMAC Holdings
IMAC
|
305 K | - | -1.77 % | $ 25.4 M | USA |
 |
The Joint Corp.
JYNT
|
9.17 M | $ 8.8 | -1.57 % | $ 127 M | USA |
 |
Addus HomeCare Corporation
ADUS
|
780 M | $ 110.59 | -0.4 % | $ 1.88 B | USA |
 |
The Ensign Group
ENSG
|
3.38 B | $ 177.13 | 0.27 % | $ 10 B | USA |
 |
Hanger
HNGR
|
398 M | - | - | $ 732 M | USA |
 |
Encompass Health Corporation
EHC
|
2.9 B | $ 107.62 | 0.54 % | $ 10.8 B | USA |
|
Novo Integrated Sciences
NVOS
|
7.55 M | - | -13.87 % | $ 1.52 M | USA |
 |
ModivCare
MODV
|
2.37 B | - | -25.23 % | $ 6.12 M | USA |
 |
Option Care Health
OPCH
|
3.45 B | $ 32.67 | 0.97 % | $ 5.61 B | USA |
 |
Oak Street Health
OSH
|
438 M | - | 0.03 % | $ 9.53 B | USA |
 |
MEDNAX
MD
|
1.54 B | $ 21.91 | 0.62 % | $ 1.83 B | USA |
 |
National HealthCare Corporation
NHC
|
811 M | $ 138.03 | -0.38 % | $ 2.12 B | USA |
 |
Healthcare Services Group
HCSG
|
1.49 B | $ 19.57 | -0.36 % | $ 1.44 B | USA |
 |
The Pennant Group
PNTG
|
558 M | $ 29.09 | -0.48 % | $ 907 M | USA |
 |
LHC Group
LHCG
|
1.4 B | - | - | $ 5.27 B | USA |
 |
Ontrak
OTRK
|
4.02 M | - | -11.98 % | $ 1.53 M | USA |
 |
Select Medical Holdings Corporation
SEM
|
1.18 B | $ 14.78 | -0.54 % | $ 1.84 B | USA |
|
Sanara MedTech
SMTI
|
7.85 M | $ 24.11 | -1.69 % | $ 200 M | USA |
 |
Surgery Partners
SGRY
|
794 M | $ 16.05 | 2.69 % | $ 2.02 B | USA |
 |
SunLink Health Systems
SSY
|
18.3 M | - | 17.98 % | $ 7.81 M | USA |
 |
U.S. Physical Therapy
USPH
|
399 M | $ 81.3 | 1.12 % | $ 1.22 B | USA |
 |
Tenet Healthcare Corporation
THC
|
8.8 B | $ 201.0 | 1.59 % | $ 19.5 B | USA |
 |
Universal Health Services
UHS
|
7.52 B | $ 227.58 | 0.28 % | $ 15.1 B | USA |
 |
Tivity Health
TVTY
|
278 M | - | 0.09 % | $ 1.6 B | USA |